ENTYVIO (vedolizumab) for injection, for intravenous use Initial U.S. Approval: 2014. Available In India.

ENTYVIO is a prescription medicine used in adults with moderate to severe ulcerative colitis or Crohn's disease. For this applicant is required to make an request application with required document. IPN, New Delhi will do the necessary process to obtain permission from Drugs Controller General (India) to import. If you have questions, please email IPN Support Team or Call Indian Pharma Network on +91 9891296838 (Mr. Tarun) / 9811747774 (Mr. Neeraj) for Price List or Cost of Medication.

ENTYVIO (vedolizumab) for injection is used for the treatment of ulcerative colitis, Crohn’s Disease..

What ENTYVIO (vedolizumab) for injection is and What it is used for?

DARZALEX is a CD38-directed cytolytic antibody indicated: • in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for the treatment of patients with multiple myeloma who have received at least one prior therapy • as monotherapy, for the treatment of patients with multiple myeloma who have received at least three prior lines of therapy including a proteasome inhibitor (PI) and an immunomodulatory agent or who are doublerefractory to a PI and an immunomodulatory agent.

How to buy ENTYVIO (vedolizumab) for injection in India and overseas?

ENTYVIO (vedolizumab) for injection suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of ENTYVIO (vedolizumab) for injection brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the ENTYVIO (vedolizumab) for injection medicine cost price in India.

The order for ENTYVIO (vedolizumab) for injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

What vedolizumab is and What it is used for?

Vedolizumab (trade name Entyvio) is a monoclonal antibody developed by Millennium Pharmaceuticals, Inc (a subsidiary of Takeda Pharmaceuticals) for the treatment of ulcerative colitis and Crohn's disease. It binds to integrin α4β7 (LPAM-1, lymphocyte Peyer's patch adhesion molecule 1, a dimer of Integrin alpha-4 and Integrin beta-7). Blocking the α4β7 integrin results in gut-selective anti-inflammatory activity. It is marketed under the trade name Entyvio.

What are the brand names available for medicines containing vedolizumab?

ENTYVIO (vedolizumab) for injection, for intravenous use Initial U.S. Approval: 2014

Generic Name: vedolizumab

Dosage Forms And Strengths of ENTYVIO (vedolizumab).

For injection: 300 mg of lyophilized vedolizumab in a single-use 20 mL vial

GET IN TOUCH
with Indian Pharma Network

IPN, Delhi can help you access to Entyvio (vedolizumab) in India. Lists the various brand names available for medicines containing vedolizumab by leading Global API Manufacturers. 1. Kynteles (vedolizumab).

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016

Mobile / WhatsApp / Phone

M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support

info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

ENTYVIO (vedolizumab) for injection suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand ENTYVIO (vedolizumab) on prescription and Import License in Patient's Name only.

For overseas patients, ENTYVIO (vedolizumab) can be made available in Send your enquiry to find ENTYVIO (vedolizumab) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for ENTYVIO (vedolizumab).

Dosage Forms and Strengths: For injection 300 mg of lyophilized vedolizumab in a single-use 20 mL vial. ReadMore

Entyvio® (vedolizumab) Shows Higher Rates of Mucosal Healing Versus TNFα-Antagonist Therapy in Ulcerative Colitis and Crohn’s Disease Patients in Comparative Effectiveness Real-World Data Analysis.
Dated: Feb 16, 2018 ReadMore

Get Access To FDA Approved Drug ENTYVIO (vedolizumab) for injection In India

Indian Pharma Network (IPN), Delhi India is a leading Pharmaceutical Distributor / Supplier / Exporter / Importer of Anti-Cancer Medicines, used in bowel disorders (ulcerative colitis, Crohn's disease) treatment. Brand Name "ENTYVIO (vedolizumab) for injection" or Generic Name "Vedolizumab for injection" can be imported for personal use under "patient name basis" treatment in Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, India. Contact us at urgent@indianpharmanetwork.co.in or call/WhatsApp at +91 9891296838 / 9811747774 to get access as per norms.